Brief ReportBrief Communication
Open Access
Serum anti-müllerian hormone levels in evaluation of chemotherapy effect on ovarian reserve in women with breast cancer
A follow-up study
Safana A. Al-Rawi, Basil O. Saleh and Manwar A. Al-Naqqash
Saudi Medical Journal July 2018, 39 (7) 733-735; DOI: https://doi.org/10.15537/smj.2018.7.21897
Safana A. Al-Rawi
From the Ministry of Health (Al-Rawi), from the Clinical Biochemistry (Saleh), Clinical Oncology (Al-Naqqash), College of Medicine, University of Baghdad, Baghdad, Iraq
M.B.Ch.B, MScBasil O. Saleh
From the Ministry of Health (Al-Rawi), from the Clinical Biochemistry (Saleh), Clinical Oncology (Al-Naqqash), College of Medicine, University of Baghdad, Baghdad, Iraq
MSc, PhDManwar A. Al-Naqqash
From the Ministry of Health (Al-Rawi), from the Clinical Biochemistry (Saleh), Clinical Oncology (Al-Naqqash), College of Medicine, University of Baghdad, Baghdad, Iraq
DMRT, MScArticle Figures & Data
Tables
In this issue
Serum anti-müllerian hormone levels in evaluation of chemotherapy effect on ovarian reserve in women with breast cancer
Safana A. Al-Rawi, Basil O. Saleh, Manwar A. Al-Naqqash
Saudi Medical Journal Jul 2018, 39 (7) 733-735; DOI: 10.15537/smj.2018.7.21897
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.